A Retrospective Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar Disc Degenerative Disease in China.

Trial Profile

A Retrospective Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar Disc Degenerative Disease in China.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Sep 2012

At a glance

  • Drugs Alternative medicine; Mecobalamin; Nonsteroidal anti-inflammatories
  • Indications Spinal disorders
  • Focus Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 25 Nov 2011 Actual patients number (478) added as reported by ClinicalTrials.gov.
    • 25 May 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
    • 25 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top